The Leslie Dan Faculty of Pharmacy group will build a database and train an AI model to help identify peptides with therapeutic potential.
Recap by typeshit. Full story at News-Medical.Net.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
A short social clip with an unnamed GLP-1 expert. The listing doesn't say which topics they get into.
Morse links out with a short warning to sellers about poking the bear. Thin on detail, so tap through for what prompted it.
Loading…